1 C
London
Friday, November 22, 2024
HomeBusinessMoolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and...

Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October

Date:

Related stories

Walters BBQ Proudly Offers Mouthwatering BBQ in Pittsburgh

Walters BBQ, a beloved Pittsburgh institution, is excited to...

GMZ Packaging Elevates Boba Tea Experience with Customizable Cups

Lids Built for Functionality GMZ understands the importance of a...

AME CEE 2025 Application Form Released for 2025-26 Session

1. Release of Application Form: 07th Oct, 2024 2. Application...

Pietro Pazzi Unveils the Leadership Chronicles Series

To view the orignal page, please visit - http://www.prlog.org/13039992-pietro-pazzi-unveils-the-leadership-chronicles-series.html WARNING -...

A-Team Group Names Winners of Its RegTech Insight Awards

 A-Team Group has announced the winners of its RegTech...

Luxembourg, Sept 5, 2024 – (ACN Newswire) – Moolec Science SA (NASDAQ:MLEC) (“The Company”, “Moolec”), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024.

GLASO™ and Piggy Sooy™ US Harvest AnnouncementGLASO™ and Piggy Sooy™ US Harvest Announcement

GLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes. As a result of the harvest, Moolec is expecting to produce between 300 to 400 tons of safflower seeds that contain high levels of GLA. To allocate most of the upcoming GLASO™ production, Moolec has secured an offtake agreement with a major global CPG company, targeting the US market in 2025. Following a successful and rigorous audit from Moolec’s CPG customer, production is set to begin in late 2024.

The Company is also developing a broader commercial strategy to reach larger markets and clients. Moolec’s GLASO™ product contains almost 3 times more GLA than conventional sources such as borage and primrose oil, making it the most concentrated GLA oil available on the market.

Piggy Sooy™ (porcine myoglobin in soybean seeds) field trials are being carried out in 3 different US locations: Ohio, Missouri and Iowa. Main purposes for the campaign are product development (sampling), seed increase and gathering of environmental and regulatory data to continue Moolec’s US-FDA approval pathway. The Team also projects a remarkable first open field performance for its bioengineered soybean Piggy Sooy™ after recent approval for cultivation from USDA-APHIS. This has set an unprecedented milestone in biotechnology last April, with Moolec becoming the first Molecular Farming company to obtain this kind of clearance for food crops growing animal proteins in US territory.

Chief Technology Officer and Co-Founder Martín Salinas stated: “Our commitment to scaling Moolec’s Molecular Farming Technology is demonstrated by our GLASO™ campaign and the field trials of Piggy Sooy™. These efforts not only reinforce our position as pioneers in the industry but also lay the foundation for sustainable solutions in agriculture and biotechnology.” He then finished by remarking: “One acre of Piggy Sooy™ could potentially produce pork meat proteins equivalent to 10 pigs, reducing water footprint, land usage and CO2 emissions. This is a clear demonstration on how we promote environmental improvements throughout all our operations. Our aim is to heal the meat production system.”

Contact Information
Press & Media
comms@moolecscience.com

Investor Relations
ir@moolecscience.com

Related Files

Moolec Confirms US Harvest And Promising Yields For Plant-Grown Products GLASO™ And Piggy Sooy™ In October – 2024.09.05

SOURCE: Moolec Science


Topic: Press release summary

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories